IL1B and type 2 diabetes mellitus: * First follow-up study evaluating IL-1β mRNA expression and serum levels in a hyperglycemic T2DM group and after glycemic normalization treatment.* Short post-intervention study time.* This study was carried out in a population with different proportions of men and women.